Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients:: Effects of IFN-β

被引:53
作者
Giorelli, M [1 ]
Livrea, P [1 ]
Trojano, M [1 ]
机构
[1] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy
关键词
D O I
10.1089/jir.2005.25.395
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neurotransmitter dopamine counteracts T cell functions through its specific receptor subtype D5R but favors T cell proliferation and adhesion when acting on D3R. We found diminished mRNA and protein levels of D5R, but not of D3R, in peripheral blood mononuclear cells (PBMCs) from untreated multiple sclerosis ( MS) patients. Dopamine reduced T cell proliferation, secretion of interferon-gamma (IFN-gamma), and production of matrix metalloproteinase-9 (MMP-9) mRNA in PBMCs from controls but not from MS patients. By contrast, reduced levels of D3R and renewed dopamine-associated regulatory functions were found in PBMCs from IFN-beta treated MS patients. Failure of the dopaminergic system of lymphocytes may lessen the threshold of T cell activation and sustain the pathogenic cascade of MS.
引用
收藏
页码:395 / 406
页数:12
相关论文
共 32 条
[1]   Dopamine, a neurotransmitter, influences the immune system [J].
Basu, S ;
Dasgupta, PS .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 102 (02) :113-124
[2]   Catecholaminergic suppression of immunocompetent cells [J].
Bergquist, J ;
Tarkowski, A ;
Ewing, A ;
Ekman, R .
IMMUNOLOGY TODAY, 1998, 19 (12) :562-567
[3]   DISCOVERY OF ENDOGENOUS CATECHOLAMINES IN LYMPHOCYTES AND EVIDENCE FOR CATECHOLAMINE REGULATION OF LYMPHOCYTE FUNCTION VIA AN AUTOCRINE LOOP [J].
BERGQUIST, J ;
TARKOWSKI, A ;
EKMAN, R ;
EWING, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) :12912-12916
[4]  
Bergquist J, 2000, ANN NY ACAD SCI, V917, P281
[5]   IS MULTIPLE-SCLEROSIS THE EQUIVALENT OF PARKINSONS-DISEASE FOR NORADRENALINE [J].
BERNEFROMELL, K ;
FROMELL, H ;
LUNDKVIST, S ;
LUNDKVIST, P .
MEDICAL HYPOTHESES, 1987, 23 (04) :409-415
[6]   The enhancement of T cell proliferation by L-dopa is mediated peripherally and does not involve interleukin-2 [J].
Carr, L ;
Tucker, A ;
Fernandez-Botran, R .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 142 (1-2) :166-169
[7]   In vivo administration of L-dopa or dopamine decreases the number of splenic IFN-γ-producing cells [J].
Carr, L ;
Tucker, A ;
Fernandez-Botran, R .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 137 (1-2) :87-93
[8]   Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis [J].
Cosentino, M ;
Zaffaroni, M ;
Marino, F ;
Bombelli, R ;
Ferrari, M ;
Rasini, E ;
Lecchini, S ;
Ghezzi, A ;
Frigo, G .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 133 (1-2) :233-240
[9]   THERAPEUTIC EFFECT OF THE D-2-DOPAMINE AGONIST BROMOCRIPTINE ON ACUTE AND RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
DIJKSTRA, CD ;
VANDERVOORT, ER ;
DEGROOT, CJA ;
HUITINGA, I ;
UITDEHAAG, BMJ ;
POLMAN, CH ;
BERKENBOSCH, F .
PSYCHONEUROENDOCRINOLOGY, 1994, 19 (02) :135-142
[10]  
Elenkov IJ, 2000, PHARMACOL REV, V52, P595